Literature DB >> 19763919

Modes of defining atherosclerosis in mouse models: relative merits and evolving standards.

Alan Daugherty1, Hong Lu, Deborah A Howatt, Debra L Rateri.   

Abstract

Mouse models have become the most common model for defining mechanisms of atherosclerotic disease. Many genetic manipulations have enabled the development of atherosclerosis in mice due to either endogenous or diet-induced hypercholesterolemia. This availability of lesion-susceptible mice has facilitated many studies using pharmacological and genetic approaches. Unfortunately, this expansive literature on mouse atherosclerosis has generated many contradictions on the role of specific pathways. A contributor to these inconsistencies may be the multiple modes in which atherosclerosis is evaluated. Also, for each specific technique, there are no consistent standards applied to the measurements. This chapter will discuss the imaging, biochemical, and compositional modes of evaluating atherosclerosis with suggestions for standard execution of these techniques.

Entities:  

Mesh:

Year:  2009        PMID: 19763919     DOI: 10.1007/978-1-60761-247-6_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Protein S-Glutathionylation Mediates Macrophage Responses to Metabolic Cues from the Extracellular Environment.

Authors:  Sarah L Ullevig; Hong Seok Kim; John D Short; Sina Tavakoli; Susan T Weintraub; Kevin Downs; Reto Asmis
Journal:  Antioxid Redox Signal       Date:  2016-05-17       Impact factor: 8.401

2.  MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4.

Authors:  A Phillip Owens; Debra L Rateri; Deborah A Howatt; Kathryn J Moore; Peter S Tobias; Linda K Curtiss; Hong Lu; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-29       Impact factor: 8.311

Review 3.  Microengineered vascular systems for drug development.

Authors:  Candice M Hovell; Yoshitaka J Sei; YongTae Kim
Journal:  J Lab Autom       Date:  2014-11-25

Review 4.  Improving the translation of animal ischemic stroke studies to humans.

Authors:  Glen C Jickling; Frank R Sharp
Journal:  Metab Brain Dis       Date:  2014-02-15       Impact factor: 3.584

5.  Deficiency of the NR4A orphan nuclear receptor NOR1 in hematopoietic stem cells accelerates atherosclerosis.

Authors:  Hua Qing; Yi Liu; Yue Zhao; Jun Aono; Karrie L Jones; Elizabeth B Heywood; Deborah Howatt; Cassi M Binkley; Alan Daugherty; Ying Liang; Dennis Bruemmer
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

6.  Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes.

Authors:  Steven Daniel Funk; Arif Yurdagul; A Wayne Orr
Journal:  Int J Vasc Med       Date:  2012-02-14

7.  Atherosclerosis and cardiac function assessment in low-density lipoprotein receptor-deficient mice undergoing body weight cycling.

Authors:  T S McMillen; E Minami; R C Leboeuf
Journal:  Nutr Diabetes       Date:  2013-06-24       Impact factor: 5.097

8.  Are Underlying Assumptions of Current Animal Models of Human Stroke Correct: from STAIRs to High Hurdles?

Authors:  Renée J Turner; Glen C Jickling; Frank R Sharp
Journal:  Transl Stroke Res       Date:  2011-02-12       Impact factor: 6.829

9.  PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction.

Authors:  Hua Sun; Ronald M Krauss; Jeffrey T Chang; Ba-Bie Teng
Journal:  J Lipid Res       Date:  2017-11-27       Impact factor: 5.922

10.  The IL-1RI Co-Receptor TILRR (FREM1 Isoform 2) Controls Aberrant Inflammatory Responses and Development of Vascular Disease.

Authors:  Sarah A Smith; Andriy O Samokhin; Mabruka Alfadi; Emer C Murphy; David Rhodes; W Mike L Holcombe; Endre Kiss-Toth; Robert F Storey; Siu-Pok Yee; Sheila E Francis; Eva E Qwarnstrom
Journal:  JACC Basic Transl Sci       Date:  2017-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.